Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
Public ClinicalTrials.gov record NCT02211560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A, Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to evaluate the efficacy and safety of phosphatidylserine (PS) on cognitive abilities in MCI
Study identification
- NCT ID
- NCT02211560
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 65 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2014
- Primary completion
- Dec 24, 2017
- Completion
- Dec 24, 2017
- Last update posted
- Feb 4, 2018
2014 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pharmacology Research Institute | Encino | California | 91316 | — |
| Pharmacology Research Institute | Los Alamitos | California | 90720 | — |
| Pharmacology Research Institute | Newport Beach | California | — | — |
| New West Physicians, PC | Golden | Colorado | 80401 | — |
| Miami Jewish Health Systems | Miami | Florida | 33137 | — |
| APG Research LLC | Orlando | Florida | 32803 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| Great Lakes Clinical Trials | Chicago | Illinois | 60640 | — |
| Memory Enhancement Center of America | Eatontown | New Jersey | 07724, | — |
| Princeton Medical Institute | Princeton | New Jersey | 08540 | — |
| Integrative Clinical Trials, LLC | Brooklyn | New York | 11229 | — |
| The Medical Research Network | New York | New York | 10128, | — |
| Lehigh Center for Clinical Research | Allentown | Pennsylvania | 18104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02211560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2018 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02211560 live on ClinicalTrials.gov.